NKTR 8-K: SEC filing
Nektar Therapeutics
Filed with the SEC on · accession 0001213900-26-119146
NKTR filed a 8-K (current report) with the SEC on Nov 13, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Nektar Therapeutics reported $952.9 million in cash and marketable securities as of September 30, 2026, and reaffirmed that this balance will extend its cash runway into the third quarter of 2028, past initial Phase 3 ZENITH AD trial data readouts in atopic dermatitis expected in summer 2028.
Key details
✦ Ask GOAX AI about this filing — what it means for NKTR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NKTR?
Click hereFrequently asked questions
What did NKTR file with the SEC on Nov 13, 2026?
NKTR filed a 8-K (SEC filing). Nektar Therapeutics reported $952.9 million in cash and marketable securities as of September 30, 2026, and reaffirmed that this balance will extend its cash runway into the third quarter of 2028, past initial Phase 3 ZENITH AD trial data readouts in atopic dermatitis expected in summer 2028.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other NKTR SEC filings
- 10-Q · SEC filingNov 13, 2026
- 8-K · SEC filingNov 12, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 8-K · SEC filingOct 1, 2026
- SCHEDULE 13G/A · SEC filingSep 28, 2026
- 8-K · Legal settlementSep 25, 2026
- 8-K · SEC filingSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
Get alerts when NKTR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days